geocappy, that is corrent.
then again, it being BMY would be hilarious. AstraZeneca and BMY where the two more sizeable BP's that were named to be acquired themselves by some of those with overly full pockets that cannot effort to let that money on the bank because it brings much more when invested in the industry.
So, if one of them would eat us (and i assume we get at least 1 share per share + cash) then we are technically looking at an acquisition of the acquisition :)
Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.